Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity—Implications for therapeutic targeting of Nrf2

Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain

Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634 · see citing works

Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution

Taguchi, K., Motohashi, H., & Yamamoto, M. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01473.x · Cited by 1,478 · see citing works

Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex

Zhang, D. D., Lo, S., Cross, J. V., Templeton, D. J., & Hannink, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10941-10953.2004 · Cited by 1,262 · see citing works

Chapter 12 Monitoring Autophagic Degradation of p62/SQSTM1

Bjørkøy, G., Lamark, T., Pankiv, S., Øvervatn, A., Brech, A., & Johansen, T. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)03612-4 · Cited by 1,145 · see citing works

The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation

Bryan, H. K., Olayanju, A., Goldring, C. E., & Park, B. K. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.11.016 · Cited by 1,026 · see citing works

An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen

Chan, K., Han, X.-D., & Kan, Y. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081082098 · Cited by 766 · see citing works

High Sensitivity of Nrf2 Knockout Mice to Acetaminophen Hepatotoxicity Associated with Decreased Expression of ARE-Regulated Drug Metabolizing Enzymes and Antioxidant Genes

Enomoto, A. (2001) · Toxicological Sciences · doi:10.1093/toxsci/59.1.169 · Cited by 728 · see citing works

Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism

Ren, D., Villeneuve, N. F., Jiang, T., Wu, T., Lau, A., Toppin, H. A., & Zhang, D. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014275108 · Cited by 673 · see citing works

Increased Protein Stability as a Mechanism That Enhances Nrf2-mediated Transcriptional Activation of the Antioxidant Response Element

Nguyen, T., Sherratt, P. J., Huang, H.-C., Yang, C. S., & Pickett, C. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207293200 · Cited by 615 · see citing works

Nrf2 signaling: An adaptive response pathway for protection against environmental toxic insults

Osburn, W. O., & Kensler, T. W. (2007) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2007.11.006 · Cited by 549 · see citing works

Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity

Okawa, H., Motohashi, H., Kobayashi, A., Aburatani, H., Kensler, T. W., & Yamamoto, M. P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.185 · Cited by 387 · see citing works

The transcription factor NRF2 protects against pulmonary fibrosis

Cho, H., Reddy, S. P., Yamamoto, M. P., & Kleeberger, S. R. (2004) · The FASEB Journal · doi:10.1096/fj.03-1127fje · Cited by 355 · see citing works

Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity

Arlt, A., Sebens, S., Krebs, S., Geismann, C., Großmann, M., Kruse, M.-L., Schreiber, S., & Schäfer, H. (2012) · Oncogene · doi:10.1038/onc.2012.493 · Cited by 332 · see citing works

Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs

Tang, X., Wang, H., Fan, L., Wu, X., Xin, A., Ren, H.-Y., & Wang, X. J. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.008 · Cited by 327 · see citing works

Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha

Wang, X. J., Hayes, J. D., Henderson, C. J., & Wolf, C. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709483104 · Cited by 310 · see citing works

Oncogenic KRAS Confers Chemoresistance by Upregulating NRF2

Tao, S., Wang, S., Moghaddam, S. J., Ooi, A., Chapman, E., Wong, P. K., & Zhang, D. D. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1439 · Cited by 291 · see citing works

Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy

Lister, A., Nedjadi, T., Kitteringham, N. R., Campbell, F., Costello, E., Lloyd, B. H., Copple, I. M., Williams, S. J., Owen, A., Neoptolemos, J. P., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-37 · Cited by 243 · see citing works

Nrf2: control of sensitivity to carcinogens

Slocum, S. L., & Kensler, T. W. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0675-4 · Cited by 219 · see citing works

Adaptation to Oxidative Stress, Chemoresistance, and Cell Survival

Landriscina, M., Maddalena, F., Laudiero, G., & Esposito, F. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2692 · Cited by 215 · see citing works

Transcriptional Regulation of Renal Cytoprotective Genes by Nrf2 and Its Potential Use as a Therapeutic Target to Mitigate Cisplatin-Induced Nephrotoxicity

Aleksunes, L. M., Goedken, M. J., Rockwell, C. E., Thomale, J., Manautou, J. E., & Klaassen, C. D. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.170084 · Cited by 178 · see citing works

p62 at the Interface of Autophagy, Oxidative Stress Signaling, and Cancer

Nezis, I. P., & Stenmark, H. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4394 · Cited by 176 · see citing works

The Keap1–Nrf2 Cell Defense Pathway – A Promising Therapeutic Target?

Copple, I. M. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-398339-8.00002-1 · Cited by 172 · see citing works

Oxidative stress, mammospheres and Nrf2–new implication for breast cancer therapy?

Wu, T., Harder, B. G., Wong, P. K., Lang, J. E., & Zhang, D. D. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22202 · Cited by 119 · see citing works

In Vitro Evaluation of Major In Vivo Drug Metabolic Pathways Using Primary Human Hepatocytes and HepaRG Cells in Suspension and a Dynamic Three-Dimensional Bioreactor System

Darnell, M., Ulvestad, M., Ellis, E. C. S., Weidolf, L. O. G., & Andersson, T. B. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.195834 · Cited by 67 · see citing works

Mechanism of eukaryotic protein synthesis inhibition by brusatol

Willingham, W., Stafford, E. A., Reynolds, S. H., Chaney, S. G., Lee, K.-H., Okano, M., & Hall, I. H. (1981) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(81)90168-4 · Cited by 36 · see citing works

Translational control of Nrf2 within the open reading frame

Pérez, Ó. C., Barrero, C. A., & Merali, S. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.052 · Cited by 23 · see citing works

Reversibility of protein synthesis inhibition by quassinoid antineoplastic agents in a rabbit reticulocyte system

Willingham, W., Considine, R. T., Chaney, S. G., Lee, K., & Hall, I. H. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90494-5 · Cited by 10 · see citing works

Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease

Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130 · see citing works

The Keap1–Nrf2–ARE Pathway As a Potential Preventive and Therapeutic Target: An Update

Lu, M., Ji, J., Jiang, Z., & You, Q. (2016) · Medicinal Research Reviews · doi:10.1002/med.21396 · Cited by 807 · see citing works

Nrf2, the Master Regulator of Anti-Oxidative Responses

Vomund, S., Schäfer, A., Parnham, M., Brüne, B., & Von Knethen, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122772 · Cited by 752 · see citing works

Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach

Cuadrado, A., Manda, G., Hassan, A., Alcaraz, M. J., Barbas, C., Daiber, A., Ghezzi, P., León, R., López, M. G., Oliva, B., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014753 · Cited by 632 · see citing works

Anti-angiogenic therapy: current challenges and future perspectives

Lopes-Coelho, F., Martins, F., Pereira, S. A., & Serpa, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073765 · Cited by 416 · see citing works

The Nrf2/HO‐1 Axis in Cancer Cell Growth and Chemoresistance

Furfaro, A. L., Traverso, N., Domenicotti, C., Piras, S., Moretta, L., Marinari, U. M., Pronzato, M. A., & Nitti, M. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1958174 · Cited by 295 · see citing works

Inhibition of cancer antioxidant defense by natural compounds

Sznarkowska, A., Kostecka, A., Meller, K., & Bielawski, K. P. (2016) · Oncotarget · doi:10.18632/oncotarget.13723 · Cited by 241 · see citing works

The KEAP1–NRF2 System as a Molecular Target of Cancer Treatment

Taguchi, K., & Yamamoto, M. (2020) · Cancers · doi:10.3390/cancers13010046 · Cited by 195 · see citing works

TMEM164 is a new determinant of autophagy-dependent ferroptosis

Liu, J., Liu, Y., Wang, Y., Li, C., Xie, Y., Klionsky, D. J., Kang, R., & Tang, D. (2022) · Autophagy · doi:10.1080/15548627.2022.2111635 · Cited by 191 · see citing works

Potential Applications of NRF2 Inhibitors in Cancer Therapy

Panieri, E., & Saso, L. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8592348 · Cited by 185 · see citing works

An update of Nrf2 activators and inhibitors in cancer prevention/promotion

Pouremamali, F., Pouremamali, A., Dadashpour, M., Soozangar, N., & Jeddi, F. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00906-3 · Cited by 172 · see citing works

Targeting NRF2 and Its Downstream Processes: Opportunities and Challenges

Torrente, L., & DeNicola, G. M. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-052220-104025 · Cited by 168 · see citing works

Potential Applications of NRF2 Modulators in Cancer Therapy

Panieri, E., Djordjević, A. B., Telkoparan‐Akillilar, P., Cevik, D., Kouretas, D., Veskoukis, A. S., Skaperda, Z., Tsatsakis, A. M., Wallace, D., Süzen, S., et al. (2020) · Antioxidants · doi:10.3390/antiox9030193 · Cited by 165 · see citing works

Acetoacetate induces hepatocytes apoptosis by the ROS‐mediated MAPKs pathway in ketotic cows

Du, X., Shi, Z., Peng, Z., Zhao, C., Zhang, Y., Wang, Z., Li, X., Liu, G., & Li, X. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25773 · Cited by 160 · see citing works

An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy

Zhu, J., Wang, H., Chen, F., Fu, J., Xu, Y., Hou, Y., Kou, H. H., Zhai, C., Nelson, M. B., Zhang, Q., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.09.010 · Cited by 162 · see citing works

Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma

Lee, J. H., Mohan, C. D., Deivasigamani, A., Jung, Y. Y., Rangappa, S., Basappa, B., Chinnathambi, A., Alahmadi, T. A., Alharbi, S. A., Garg, M., et al. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.07.004 · Cited by 142 · see citing works

Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes

Solvay, M., Pfänder, P., Klaessens, S., Pilotte, L., Stroobant, V., Lamy, J., Naulaerts, S., Spillier, Q., Frédérick, R., Plaen, E. D., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-006728 · Cited by 147 · see citing works

Brusatol overcomes chemoresistance through inhibition of protein translation

Harder, B. G., Tian, W., Clair, J. J. L., Tan, A. C., Ooi, A., Chapman, E., & Zhang, D. D. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22609 · Cited by 137 · see citing works

Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells

Minaei, A., Sabzichi, M., Ramezani, F., Hamishehkar, H., & Samadi, N. (2016) · Molecular Biology Reports · doi:10.1007/s11033-016-3942-x · Cited by 136 · see citing works

The Relationship of Redox With Hallmarks of Cancer: The Importance of Homeostasis and Context

Xing, F., Hu, Q., Qin, Y., Xu, J., Zhang, B., Yu, X., & Wang, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.862743 · Cited by 136 · see citing works

Strange Bedfellows: Nuclear Factor, Erythroid 2-Like 2 (Nrf2) and Hypoxia-Inducible Factor 1 (HIF-1) in Tumor Hypoxia

Toth, R. K., & Warfel, N. A. (2017) · Antioxidants · doi:10.3390/antiox6020027 · Cited by 130 · see citing works

Multifaceted Roles of Glutathione and Glutathione-Based Systems in Carcinogenesis and Anticancer Drug Resistance

Hatem, E., Banna, N. E., & Huang, M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7134 · Cited by 126 · see citing works

Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway

Xiang, Y., Ye, W., Huang, C., Yu, D., Chen, H., Deng, T., Zhang, F., Lou, B., Zhang, J., Shi, K., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2360427 · Cited by 123 · see citing works

Therapeutic Potential of Plants and Plant Derived Phytochemicals against Acetaminophen-Induced Liver Injury

Subramanya, S. B., Venkataraman, B., Meeran, M. F. N., Goyal, S. N., Patil, C. R., & Ojha, S. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123776 · Cited by 128 · see citing works

Application of Mass Spectrometry Profiling to Establish Brusatol as an Inhibitor of Global Protein Synthesis

Vartanian, S., Ma, T. P., Lee, J., Haverty, P. M., Kirkpatrick, D. S., Yu, K., & Stokoe, D. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.055509 · Cited by 118 · see citing works

Glutathione system in animal model of solid tumors: From regulation to therapeutic target

Corso, C. R., & Acco, A. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.05.014 · Cited by 117 · see citing works

A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer

Choi, E.-J., Jung, B.-J., Lee, S.-H., Yoo, H.-S., Shin, E.-A., Ko, H., Chang, S., Kim, S.-Y., & Jeon, S.-M. (2017) · Oncogene · doi:10.1038/onc.2017.153 · Cited by 115 · see citing works

Obesity and NRF2-mediated cytoprotection: Where is the missing link?

Mihaylova, L. V., Savova, M. S., Amirova, K. M., Dinkova‐Kostova, A. T., & Georgiev, M. I. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104760 · Cited by 108 · see citing works

Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK/p38 MAPK/NF-κb/Stat3/Bcl-2 signaling pathway

Xiang, Y., Ye, W., Huang, C., Lou, B., Zhang, J., Yu, D., Huang, X., Chen, B., & Zhou, M. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.133 · Cited by 107 · see citing works

Blockade of Glutathione Metabolism in IDH1 -Mutated Glioma

Tang, X., Fu, X., Liu, Y., Yu, D., Cai, S. J., & Yang, C. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0103 · Cited by 100 · see citing works

Brusatol Enhances the Radiosensitivity of A549 Cells by Promoting ROS Production and Enhancing DNA Damage

Sun, X., Wang, Q., Wang, Y., Du, L., Xu, C., & Liu, Q. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17070997 · Cited by 99 · see citing works

Comprehensive anti-tumor effect of Brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K/Akt/mTOR pathway in hepatocellular carcinoma

Ye, R., Dai, N., He, Q., Guo, P., Xiang, Y., Zhang, Q., Hong, Z., & Zhang, Q. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.065 · Cited by 98 · see citing works

Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis

Carlisi, D., Buttitta, G., Fiore, R. D., Scerri, C. A., Drago‐Ferrante, R., Vento, R., & Tesoriere, G. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.94 · Cited by 93 · see citing works

Targeting IDH1-Mutated Malignancies with NRF2 Blockade

Liu, Y., Lu, Y., Celiku, O., Li, A., Wu, Q., Zhou, Y., & Yang, C. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy230 · Cited by 91 · see citing works

Targeting NRF2 to treat cancer

Sivinski, J., Zhang, D. D., & Chapman, E. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.003 · Cited by 90 · see citing works

Contradictory roles of Nrf2/Keap1 signaling pathway in cancer prevention/promotion and chemoresistance

Jeddi, F., Soozangar, N., Sadeghi, M. R., Somi, M. H., & Samadi, N. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.03.008 · Cited by 90 · see citing works

Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2

Karathedath, S., Rajamani, B. M., Aalam, S. M. M., Abraham, A., Varatharajan, S., Krishnamurthy, P. C., Mathews, V., Velayudhan, S. R., & Balasubramanian, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177227 · Cited by 88 · see citing works

Brusatol-Mediated Inhibition of c-Myc Increases HIF-1α Degradation and Causes Cell Death in Colorectal Cancer under Hypoxia

Oh, E., Kim, C. W., Kim, H. G., Lee, J., & Park, H. J. (2017) · Theranostics · doi:10.7150/thno.20861 · Cited by 83 · see citing works

Role of Nrf2 Signaling Cascade in Breast Cancer: Strategies and Treatment

Kumar, H., Kumar, R. M., Bhattacharjee, D., Somanna, P., & Jain, V. K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.720076 · Cited by 75 · see citing works

Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks

Xu, K., Ma, J., Hall, S. R. R., Peng, R., Yang, H., & Yao, F. (2023) · Theranostics · doi:10.7150/thno.80184 · Cited by 75 · see citing works

Nuclear Factor (Erythroid-Derived 2)-Like 2 and Thioredoxin-1 in Atherosclerosis and Ischemia/Reperfusion Injury in the Heart

Jakobs, P., Serbulea, V., Leitinger, N., Eckers, A., & Haendeler, J. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6795 · Cited by 74 · see citing works

Nrf2 induces cisplatin resistance via suppressing the iron export related gene SLC40A1 in ovarian cancer cells

Wu, J., Bao, L., Zhang, Z., & Yi, X. (2017) · Oncotarget · doi:10.18632/oncotarget.19548 · Cited by 71 · see citing works

Natural Nrf2 Inhibitors: A Review of Their Potential for Cancer Treatment

Zhang, J., Xu, H., Zhu, J., Dou, Y., Xian, Y., & Lin, Z. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.82401 · Cited by 70 · see citing works

Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.

Daga, M., Pizzimenti, S., Dianzani, C., Cucci, M. A., Cavalli, R., Grattarola, M., Ferrara, B., Scariot, V., Trotta, F., & Barrera, G. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.10.034 · Cited by 69 · see citing works

Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs

Telkoparan‐Akillilar, P., Süzen, S., & Saso, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20082025 · Cited by 66 · see citing works

Biological and therapeutic activities of thymoquinone: Focus on the Nrf2 signaling pathway

Talebi, M., Talebi, M., Farkhondeh, T., & Samarghandian, S. (2020) · Phytotherapy Research · doi:10.1002/ptr.6905 · Cited by 65 · see citing works

Emerging roles of Nrf2 signal in non-small cell lung cancer

Tian, Y., Liu, Q., He, X., Yuan, X., Chen, Y., Chu, Q., & Wu, K. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0246-5 · Cited by 65 · see citing works

The see-saw of Keap1-Nrf2 pathway in cancer

Pandey, P., Singh, A. K., Singh, M., Tewari, M., Shukla, H. S., & Gambhir, I. S. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.02.006 · Cited by 65 · see citing works

Targeting fatty acid oxidation enhances response to HER2-targeted therapy

Nandi, I., Ji, L., Smith, H. W., Avizonis, D. Z., Papavasiliou, V., Lavoie, C. A., Pacis, A., Attalla, S. S., Sanguin‐Gendreau, V., & Muller, W. J. (2024) · Nature Communications · doi:10.1038/s41467-024-50998-3 · Cited by 67 · see citing works

The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer

Evans, J. P., Winiarski, B. K., Sutton, P. A., Jones, R. P., Ressel, L., Duckworth, C. A., Pritchard, D. M., Lin, Z., Fretwell, V. L., Tweedle, E. M., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25497 · Cited by 62 · see citing works

Nrf2 Inhibitor, Brusatol in Combination with Trastuzumab Exerts Synergistic Antitumor Activity in HER2-Positive Cancers by Inhibiting Nrf2/HO-1 and HER2-AKT/ERK1/2 Pathways

Yang, Y., Tian, Z., Guo, R., & Ren, F. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9867595 · Cited by 60 · see citing works

Celastrol attenuates angiotensin II mediated human umbilical vein endothelial cells damage through activation of Nrf2/ERK1/2/Nox2 signal pathway

Li, M., Liu, X. Z., He, Y., Zheng, Q., Wang, M., Wu, Y. C., Zhang, Y., & Wang, C. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.01.027 · Cited by 59 · see citing works

ROS Modulator Molecules with Therapeutic Potential in Cancers Treatments

Nicco, C., & Batteux, F. (2017) · Molecules · doi:10.3390/molecules23010084 · Cited by 59 · see citing works

Salidroside Reduces Inflammation and Brain Injury After Permanent Middle Cerebral Artery Occlusion in Rats by Regulating PI3K/PKB/Nrf2/NFκB Signaling Rather than Complement C3 Activity

Zhang, X.-L., Lai, W., Ying, X., Xu, L., Chu, K., Brown, J., Chen, L., & Hong, G. (2019) · Inflammation · doi:10.1007/s10753-019-01045-7 · Cited by 57 · see citing works

Baicalin Relieves LPS-Induced Lung Inflammation via the NF-κB and MAPK Pathways

Shen, B., Zhang, H., Zhu, Z., Ling, Z., Zeng, F., Wang, Y., & Wang, J. (2023) · Molecules · doi:10.3390/molecules28041873 · Cited by 56 · see citing works

Keap1–Nrf2 signalling in pancreatic cancer

Hayes, A. J., Skouras, C., Haugk, B., & Charnley, R. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.06.017 · Cited by 56 · see citing works

Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo

Dibra, D., Xiong, S., Moyer, S. M., El‐Naggar, A. K., Qi, Y., Su, X., Kong, E., Korkut, A., & Lozano, G. (2024) · Science Advances · doi:10.1126/sciadv.adk1835 · Cited by 62 · see citing works

Apoptotic activities of brusatol in human non-small cell lung cancer cells: Involvement of ROS-mediated mitochondrial-dependent pathway and inhibition of Nrf2-mediated antioxidant response

Xie, J., Lai, Z., Zheng, X., Liao, H., Xian, Y., Li, Q., Wu, J., Ip, S., Xie, Y., Chen, J., et al. (2021) · Toxicology · doi:10.1016/j.tox.2021.152680 · Cited by 55 · see citing works

Brusatol: A potential sensitizing agent for cancer therapy from Brucea javanica

He, T., Zhou, F., Su, A., Zhang, Y., Xing, Z., Mi, L., Li, Z., & Wu, W. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114134 · Cited by 55 · see citing works

Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway

Wang, Y., Wang, Y., Zhang, Z., Park, J. Y., Guo, D., Liao, H., Yi, X., Zheng, Y., Zhang, D. D., Chambers, S. K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7004 · Cited by 53 · see citing works

6-Shogaol, an active compound of ginger, alleviates allergic dermatitis-like skin lesions via cytokine inhibition by activating the Nrf2 pathway

Park, G., Oh, D., Lee, M. G., Lee, C. E., & Kim, Y. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.08.019 · Cited by 53 · see citing works

Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy

Bayındır, Z. S., Losada‐Barreiro, S., Bravo‐Díaz, C., Sova, M., Kristl, J., & Saso, L. (2021) · Antioxidants · doi:10.3390/antiox10050685 · Cited by 55 · see citing works

Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression

Gjyshi, O., Roy, A., Dutta, S., Veettil, M. V., Dutta, D., & Chandran, B. (2015) · Journal of Virology · doi:10.1128/jvi.00895-15 · Cited by 51 · see citing works

Keap1–Nrf2 pathway: A promising target towards lung cancer prevention and therapeutics

Tong, Y., Zhang, B., Fan, Y., & Lin, N. (2015) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2015.09.002 · Cited by 51 · see citing works

Melatonin enhances porcine embryo development via the Nrf2/ARE signaling pathway

Kim, E. H., Kim, G. A., Taweechaipaisankul, A., Lee, S. H., Qasim, M., Ahn, C., & Lee, B. C. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-19-0093 · Cited by 50 · see citing works

p62/SQSTM1/Keap1/NRF2 Axis Reduces Cancer Cells Death-Sensitivity in Response to Zn(II)–Curcumin Complex

Garufi, A., Giorno, E., Montani, M. S. G., Pistritto, G., Crispini, A., Cirone, M., & D’Orazi, G. (2021) · Biomolecules · doi:10.3390/biom11030348 · Cited by 50 · see citing works

UVA Irradiation Enhances Brusatol‐Mediated Inhibition of Melanoma Growth by Downregulation of the Nrf2‐Mediated Antioxidant Response

Wang, M., Shi, G., Bian, C., Nisar, M. F., Guo, Y., Wu, Y., Li, W., Huang, X. H., Jiang, X., Bartsch, J. W., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9742154 · Cited by 49 · see citing works

Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells

Panieri, E., & Saso, L. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8146 · Cited by 46 · see citing works

Chrysin loaded nanostructured lipid carriers (NLCs) triggers apoptosis in MCF-7 cancer cells by inhibiting the Nrf2 pathway

Sabzichi, M., Mohammadian, J., Bazzaz, R., Pirouzpanah, M. B., Shaaker, M., Hamishehkar, H., Chavoshi, H., Salehi, R., & Samadi, N. (2017) · Process Biochemistry · doi:10.1016/j.procbio.2017.05.024 · Cited by 47 · see citing works

Stigmasterol sensitizes endometrial cancer cells to chemotherapy by repressing Nrf2 signal pathway

Liao, H., Zhu, D., Bai, M., Chen, H., Yan, S., Yu, J. Q., Zhu, H., Zheng, W., & Fan, G. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01470-x · Cited by 47 · see citing works

Recent progress in the development of small molecule Nrf2 modulators: a patent review (2012-2016)

Sun, H., Zhu, J., Lin, H., Gu, K. X., & Feng, F. (2017) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1325464 · Cited by 46 · see citing works

Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy

Kannan, S., Irwin, M. E., Herbrich, S. M., Cheng, T., Patterson, L. L., Aitken, M. J. L., Bhalla, K. N., You, M. J., Konopleva, M. Y., Zweidler‐McKay, P. A., et al. (2022) · Antioxidants · doi:10.3390/antiox11040717 · Cited by 44 · see citing works

Nrf2: a potential therapeutic target for naturally occurring anticancer drugs?

Catanzaro, E., Calcabrini, C., Turrini, E., Sestili, P., & Fimognari, C. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1351549 · Cited by 45 · see citing works

Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo

Bovilla, V. R., Kuruburu, M. G., Bettada, V. G., Krishnamurthy, J., Sukocheva, O. A., Thimmulappa, R. K., Shivananju, N. S., Balakrishna, J. P., & Madhunapantula, S. V. (2021) · Biomedicines · doi:10.3390/biomedicines9091119 · Cited by 44 · see citing works

A strategy to prevent atherosclerosis via TNF receptor regulation

Kim, C. W., Oh, E., & Park, H. J. (2021) · The FASEB Journal · doi:10.1096/fj.202000764r · Cited by 44 · see citing works

Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells

Chen, H., Lai, Z., Liao, H., Xie, J., Xian, Y., Chen, Y., Ip, S., Lin, Z., & Su, Z. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3372 · Cited by 43 · see citing works

Nrf2 Is a Potential Modulator for Orchestrating Iron Homeostasis and Redox Balance in Cancer Cells

Zhang, L., Zhang, J., Jin, Y., Yao, G., Zhao, H., Qiao, P., & Wu, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.728172 · Cited by 42 · see citing works

Melatonin-Nrf2 Signaling Activates Peroxisomal Activities in Porcine Cumulus Cell-Oocyte Complexes

Kim, E. H., Ridlo, M. R., Lee, B. C., & Kim, G. A. (2020) · Antioxidants · doi:10.3390/antiox9111080 · Cited by 42 · see citing works

Oxidative stress via inhibition of the mitochondrial electron transport and Nrf-2-mediated anti-oxidative response regulate the cytotoxic activity of plumbagin

Kapur, A., Beres, T. M., Rathi, K., Nayak, A. P., Czarnecki, A. A., Felder, M. A. R., Gillette, A. A., Ericksen, S. S., Sampene, E., Skala, M. C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19261-w · Cited by 41 · see citing works

Cancer Chemopreventive Role of Dietary Terpenoids by Modulating Keap1-Nrf2-ARE Signaling System—A Comprehensive Update

Siraj, M. A., Islam, M. A., Fahad, M. A. A., Kheya, H. R., Xiao, J., & Simal‐Gándara, J. (2021) · Applied Sciences · doi:10.3390/app112210806 · Cited by 46 · see citing works

Upregulation of Nox4 induces a pro-survival Nrf2 response in cancer-associated fibroblasts that promotes tumorigenesis and metastasis, in part via Birc5 induction

Mir, S. U. R., Ormsbee, B. D., Griess, B., Vengoji, R., Tom, E. C., Kosmacek, E. A., Oberley‐Deegan, R. E., Talmon, G. A., Band, V., & Teoh-Fitzgerald, M. L. T. (2022) · Breast Cancer Research · doi:10.1186/s13058-022-01548-6 · Cited by 38 · see citing works

Endothelial Immune Activation by Medin: Potential Role in Cerebrovascular Disease and Reversal by Monosialoganglioside‐Containing Nanoliposomes

Karamanova, N., Truran, S., Serrano, G. E., Beach, T. G., Madine, J., Weissig, V., Davies, H. A., Veldhuizen, J., Nikkhah, M., Hansen, M., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014810 · Cited by 40 · see citing works

Targeting NRF2-Governed Glutathione Synthesis for SDHB-Mutated Pheochromocytoma and Paraganglioma

Liu, Y., Pang, Y. K., Caisová, V., Ding, J., Yu, D., Zhou, Y., Huynh, T., Ghayee, H. K., Pacák, K., & Yang, C. (2020) · Cancers · doi:10.3390/cancers12020280 · Cited by 38 · see citing works

Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway

Guo, S., Zhang, J., Wei, C., Lü, Z.-Y., Cai, R., Pan, D., Zhang, H., Liang, B., & Zhang, Z. (2020) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04083-3 · Cited by 37 · see citing works

LBP reduces theinflammatory injuryof kidney in septic rat and regulates the Keap1-Nrf2∕ARE signaling pathway

Huang, Y., Zhou, F., Shen, C., Wang, H., & Xiao, Y. (2019) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-865020190010000003 · Cited by 36 · see citing works

Brusatol: A potential anti-tumor quassinoid from Brucea javanica

Yu, X., Shang, X., Huang, X., Yao, G., & Song, S. (2020) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2020.05.007 · Cited by 36 · see citing works

A NRF2 inhibitor selectively sensitizes KEAP1 mutant tumor cells to cisplatin and gefitinib by restoring NRF2-inhibitory function of KEAP1 mutants

Aboulkassim, T., Tian, X., Liu, Q., Qiu, D., Hancock, M. A., Wu, J. H., & Batist, G. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113104 · Cited by 35 · see citing works

Nrf2 inhibition affects cell cycle progression during early mouse embryo development

Lin, Y., Sui, L., Wu, R., Ma, R., Fu, H., Xu, J., Qiu, X., & Chen, L. (2017) · Journal of Reproduction and Development · doi:10.1262/jrd.2017-042 · Cited by 35 · see citing works

Overview of Ferroptosis and Synthetic Lethality Strategies

Kinowaki, Y., Taguchi, T., Onishi, I., Kirimura, S., Kitagawa, M., & Yamamoto, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179271 · Cited by 35 · see citing works

The therapeutic role of nutraceuticals targeting the Nrf2/ HO ‐1 signaling pathway in liver cancer

Alharbi, K. S., Almalki, W. H., Albratty, M., Meraya, A. M., Najmi, A., Vyas, G. K., Singh, S. K., Dua, K., & Gupta, G. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14357 · Cited by 34 · see citing works

Curcumin improves asthenozoospermia by inhibiting reactive oxygen species reproduction through nuclear factor erythroid 2‐related factor 2 activation

Zhou, Q., Wu, X., Liu, Y., Wang, X., Ling, X., Ge, H., & Zhang, J. (2019) · Andrologia · doi:10.1111/and.13491 · Cited by 33 · see citing works

A Complementary Chemical and Genomic Screening Approach for Druggable Targets in the Nrf2 Pathway and Small Molecule Inhibitors to Overcome Cancer Cell Drug Resistance

Matthews, J., Liang, X., Paul, V. J., & Luesch, H. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b01025 · Cited by 33 · see citing works

Importance of the Keap1-Nrf2 pathway in NSCLC: Is it a possible biomarker? (Review)

Rodríguez, R. B. (2018) · Biomedical Reports · doi:10.3892/br.2018.1143 · Cited by 32 · see citing works

Small Molecular Nrf2 Inhibitors as Chemosensitizers for Cancer Therapy

Lin, H., Qiao, Y., Yang, H., Nan, Q., Qu, W., Feng, F., Liu, W., Chen, Y., & Sun, H. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0285 · Cited by 30 · see citing works

Brusatol inhibits the response of cultured beta-cells to pro-inflammatory cytokines in vitro

Turpaev, K. T., & Welsh, N. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.124 · Cited by 29 · see citing works

The toxic effects and possible mechanisms of Brusatol on mouse oocytes

Ma, R., Li, H., Yu, Z., Lin, Y., Qiu, X., Xie, M., & Yao, B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177844 · Cited by 29 · see citing works

Shikonin Attenuates Acetaminophen-Induced Hepatotoxicity by Upregulation of Nrf2 through Akt/GSK3β Signaling

Li, H., Chen, Y., Zhang, J., Chen, X., Li, Z., Liu, B., & Zhang, L. (2018) · Molecules · doi:10.3390/molecules24010110 · Cited by 28 · see citing works

Neuroprotective Effect of Natural Alkaloid Fangchinoline Against Oxidative Glutamate Toxicity: Involvement of Keap1-Nrf2 Axis Regulation

Bao, F., Tao, L.-X., & Zhang, H. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00711-6 · Cited by 28 · see citing works

NF‐E2–Related Factor 2 Regulates Interferon Receptor Expression and Alters Macrophage Polarization in Lupus

Han, S., Zhuang, H., Lee, P. Y., Li, M., Yang, L., Nigrovic, P. A., & Reeves, W. H. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41383 · Cited by 28 · see citing works

Perspectives on the Clinical Development of NRF2-Targeting Drugs

Lastra, D., Fernández-Ginés, R., Manda, G., & Cuadrado, A. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_381 · Cited by 28 · see citing works

Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism

Ren, D., Villeneuve, N. F., Jiang, T., Wu, T., Lau, A., Toppin, H. A., & Zhang, D. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014275108 · Cited by 673 · see citing works

Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2; NRF2)

(2011) · Science-Business eXchange · doi:10.1038/scibx.2011.99

Roles of Nrf2 in drug and chemical toxicity

Clarke, J., Murray, J. B., Park, B. K., & Copple, I. M. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.10.004 · Cited by 23 · see citing works

Brusatol overcomes chemoresistance through inhibition of protein translation

Harder, B. G., Tian, W., Clair, J. J. L., Tan, A. C., Ooi, A., Chapman, E., & Zhang, D. D. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22609 · Cited by 137 · see citing works

Faut-il s’intéresser aux protéines édulcorantes ?

Lavaud, F., & Dutau, G. (2015) · Revue française d'allergologie · doi:10.1016/j.reval.2015.11.001